Cargando…
NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo
Despite new treatments introduced over the past several years, metastatic melanoma remains difficult to cure. Although melanoma in situ (MIS) has better prognosis, it relies heavily on thorough surgical excision, where ill-defined margins can pose a challenge to successful removal, potentially leadi...
Autores principales: | Swenson, Steve, Silva-Hirschberg, Catalina, Wang, Weijun, Singh, Anupam, Hofman, Florence M., Chen, Kristen L., Schönthal, Axel H., Chen, Thomas C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319336/ https://www.ncbi.nlm.nih.gov/pubmed/30651933 http://dx.doi.org/10.18632/oncotarget.26443 |
Ejemplares similares
-
Cytotoxic impact of a perillyl alcohol–temozolomide conjugate,
NEO212, on cutaneous T-cell lymphoma in vitro
por: Silva-Hirschberg, Catalina, et al.
Publicado: (2019) -
Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice
por: Cho, Hee-Yeon, et al.
Publicado: (2020) -
Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivo
por: Chen, Thomas C., et al.
Publicado: (2015) -
NEO212, a Perillyl Alcohol-Temozolomide Conjugate, Triggers Macrophage Differentiation of Acute Myeloid Leukemia Cells and Blocks Their Tumorigenicity
por: Chen, Thomas C., et al.
Publicado: (2022) -
Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia
por: Schönthal, Axel H., et al.
Publicado: (2021)